Skip to main content

Table 2 Baseline, early and late post-biopsy HRQoL measurements

From: Health-related Quality of Life in Vacuum-Assisted Breast Biopsy: short-term effects, long-term effects and predictors

Variables

Baseline

(mean ± SD)

Early post-biopsy measurement

(mean ± SD)

p§

Late post-biopsy measurement

(mean ± SD)

p

Practical interpretation

EQ-5D dimensions and indices

      

Mobility*

1.41 ± 0.49

1.42 ± 0.50

0.782

1.27 ± 0.45

0.011

Deterioration at baseline

Self-care*

1.03 ± 0.17

1.03 ± 0.17

1.000

1.09 ± 0.33

0.058

No changes

Usual activities*

1.24 ± 0.43

1.31 ± 0.46

0.021

1.23 ± 0.45

0.835

Short-term deterioration

Pain/discomfort*

1.53 ± 0.59

1.55 ± 0.61

0.977

1.71 ± 0.54

0.004

Long-term deterioration

Anxiety/depression*

1.98 ± 0.65

1.52 ± 0.61

<0.0001

1.77 ± 0.60

0.002

Deterioration at baseline

VAS "thermometer"

68.8 ± 18.4

67.5 ± 18.1

0.406

75.5 ± 15.6

0.003

Deterioration at baseline

EQ-5D index

(TTO method)

0.729 ± 0.224

0.787 ± 0.208

0.005

0.769 ± 0.225

0.251

Deterioration at baseline

EQ-5D index

(VAS method)

0.834 ± 0.076

0.854 ± 0.062

0.038

0.845 ± 0.085

0.324

Deterioration at baseline

SF-36 dimensions and scores

      

Physical functioning

86.2 ± 19.5

85.2 ± 18.9

0.641

80.1 ± 19.4

0.0001

Long-term deterioration

Bodily pain

78.3 ± 26.4

76.3 ± 27.5

0.414

65.5 ± 30.5

0.0004

Long-term deterioration

General Health

64.5 ± 21.3

68.5 ± 22.5

0.067

65.6 ± 19.0

0.700

No changes

Vitality

60.6 ± 19.5

60.8 ± 18.7

0.999

59.6 ± 21.9

0.697

No changes

Social Functioning

75.3 ± 24.7

74.6 ± 25.3

0.496

73.4 ± 27.6

0.925

No changes

Mental Health

58.8 ± 19.3

60.4 ± 20.2

0.139

62.8 ± 21.1

0.030

Deterioration at baseline

Role functioning-physical

80.1 ± 33.1

72.3 ± 39.2

0.008

73.4 ± 39.0

0.098

Short-term deterioration

Role functioning-emotional

71.0 ± 37.0

70.9 ± 37.1

0.650

66.2 ± 42.1

0.347

No changes

Physical Component Scale

52.5 ± 8.6

51.8 ± 7.9

0.234

48.5 ± 9.3

0.004

Long-term deterioration

Mental Component Scale

40.1 ± 11.8

41.5 ± 11.6

0.270

41.9 ± 14.3

0.568

No changes

  1. § p-values derived from Wilcoxon matched-pairs signed-ranks test (early post-biopsy measurement vs. baseline)
  2. †: p-values derived from Wilcoxon matched-pairs signed-ranks test (late post-biopsy measurement vs. baseline)
  3. *: Measures where a higher score denotes a worse health status